US Patent Issued to TAEJOON PHARMACEUTICAL on March 17 for "Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof" (South Korean Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,126, issued on March 17, was assigned to TAEJOON PHARMACEUTICAL Co. LTD. (Seoul, South Korea).

"Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof" was invented by Joon Youb Lee (Seoul, South Korea), Youn Jae Shin (Suwon-si, South Korea), Hyun Won Seo (Jeonju-si, South Korea) and Dae Hun Kim (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a nanoemulsion ophthalmic composition and a preparation method thereof, wherein the nanoemulsion ophthalmic composition is obtained by mixing cyclosporine, castor oil, hydrophilic and hydrophobic emulsifiers...